Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Pharmacopeia logo — Innovating to meet critical health challenges with advanced...

Pharmacopeia

Innovating to meet critical health challenges with advanced therapeutic discoveries and developments.

Founded 1993 Venture round Total: $7.63M Biopharma, Biotechnology +1

General Information

Company Name Pharmacopeia
Founded Year 1993
Founders / Decision Makers
Team member
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Pharmacopeia. To contact Pharmacopeia, visit pharmacopeia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pharmacopeia compare?

A PDF of Pharmacopeia and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pharmacopeia soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pharmacopeia

The biopharmaceutical company Pharmacopeia is focused on addressing critical medical needs through therapeutic discoveries and developments. It has a diverse internal program portfolio, including PS433540, a dual-acting angiotensin and endothelin receptor antagonist, and PS178990, a muscle-selective SARM agonist, both in clinical development stages. The company’s pipeline also includes PS031291, a preclinical product targeting multiple myeloma and inflammatory conditions, and JAK3 inhibitors for dermatologic and ocular diseases. Pharmacopeia has strategically aligned with major pharmaceutical entities such as Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, and Wyeth Pharmaceuticals. Established in 1993 as Pharmacopeia Drug Discovery, Inc., and later renamed in 2007, the company operates as a subsidiary of Ligand Pharmaceuticals Inc. in Cranbury, New Jersey. In 27 July 2005, the company secured a $7.63M Venture Round investment from Senvest Capital, Highbridge Capital Management, Iroquois Capital, ClearArc Capital, Nite Capital Management, Clarion Capital Partners, Carpe Diem Capital Management, Downsview Capital, and Balyasny Asset Management.

Business keywords: biopharmaceutical, therapeutics, clinical development, cardiovascular diseases, renal diseases, muscle-selective SARM agonist, preclinical development, multiple myeloma, inflammatory conditions, JAK3 inhibitors, strategic alliances, pharmaceutical company, drug discovery, Ligand Pharmaceuticals, New Jersey

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $7.63M 9
Senvest Capital Highbridge Capital Management Iroquois Capital
Senvest Capital, Highbridge Capital Management +7
27 Jul 2005

Pharmacopeia Alternatives & Competitors

View All Alternatives
Pharmacopeia vs
Encysive Pharmaceuticals
Encysive Pharmaceuticals

Leading the fight against vascular and inflammatory diseases with groundbreaking synthetic and small...

Private Equity
Biotechnology, Pharmaceutical
Pharmacopeia vs
Promedior
Promedior

Pioneering advanced therapies to heal fibrotic and inflammatory diseases at their source, enhancing...

Venture round
Biopharma, Biotechnology
Pharmacopeia vs
Sudo Biosciences
Sudo Biosciences United States

Developing precision TYK2 therapeutics.

Series B
27 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Pharmacopeia

Innovating to meet critical health challenges with advanced therapeutic discoveries and developments.
Pharmacopeia was founded in 1993.
Pharmacopeia operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on biopharmaceutical, therapeutics, clinical development and cardiovascular diseases.
Pharmacopeia has completed 1 funding round, raising a total of $7.63M. The latest funding stage is Venture round.
Top alternatives and competitors to Pharmacopeia include Encysive Pharmaceuticals, Promedior, Sudo Biosciences, Azome Therapeutics, Zevra Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pharmacopeia and Encysive Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pharmacopeia, https://bouncewatch.com/company/pharmacopeia, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes